Tech funds are hemorrhaging cash: Sell this stock now

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

Kashif Rashid Biography and Net Worth

General Counsel of Nevro

Kashif Rashid joined Nevro in 2017 and serves as General Counsel of the company. Mr. Rashid has over 20 years of broad legal experience, with a particular focus in medical devices and healthcare. Mr. Rashid previously served as Deputy General Counsel at St. Jude Medical, a medical device company, where he had responsibility for various aspects of the legal function, including commercial, business development and corporate governance and securities. Following the acquisition of St. Jude Medical by Abbott, Mr. Rashid moved to Atara Biotherapeutics, a bay-area biotech focused on T-cell immunotherapy, as Vice President, Legal. Prior to St. Jude Medical, Mr. Rashid served in roles of increasing responsibility at General Electric's Healthcare business, Loews Corporation and Kaye Scholer, LLP. Mr. Rashid received his B.S. in Business Administration from The George Washington University and his JD from Georgetown University Law Center.

What is Kashif Rashid's net worth?: The estimated net worth of Kashif Rashid is at least $241,937.52 as of May 9th, 2022. Ms. Rashid owns 53,526 shares of Nevro stock worth more than $241,938 as of November 18th. This net worth evaluation does not reflect any other investments that Ms. Rashid may own. Additionally, Ms. Rashid receives an annual salary of $629,620.00 as General Counsel at Nevro. Learn More about Kashif Rashid's net worth.
How old is Kashif Rashid?: Ms. Rashid is currently 50 years old. There are 6 older executives and no younger executives at Nevro. The oldest executive at Nevro is Dr. David Caraway M.D., Ph.D., Senior VP & Chief Medical Officer, who is 67 years old. Learn More on Kashif Rashid's age.
What is Kashif Rashid's salary?: As the General Counsel of Nevro Corp., Ms. Rashid earns $629,620.00 per year. There are 2 executives that earn more than Ms. Rashid. The highest earning executive at Nevro is Mr. Kevin R. Thornal, President, CEO & Director, who commands a salary of $1,370,000.00 per year. Learn More on Kashif Rashid's salary.
How do I contact Kashif Rashid?: The corporate mailing address for Ms. Rashid and other Nevro executives is 1800 BRIDGE PARKWAY, REDWOOD CITY CA, 94065. Nevro can also be reached via phone at (650) 251-0005 and via email at [email protected]. Learn More on Kashif Rashid's contact information.
Has Kashif Rashid been buying or selling shares of Nevro?: Kashif Rashid has not been actively trading shares of Nevro over the course of the past ninety days. Most recently, on Monday, May 9th, Kashif Rashid bought 2,250 shares of Nevro stock. The stock was acquired at an average cost of $44.50 per share, with a total value of $100,125.00. Following the completion of the transaction, the general counsel now directly owns 53,526 shares of the company's stock, valued at $2,381,907. Learn More on Kashif Rashid's trading history.
Who are Nevro's active insiders?: Nevro's insider roster includes Michael DeMane (Director), D. Grossman (CEO), Kevin O'Boyle (Director), Kashif Rashid (General Counsel), and Elizabeth Weatherman (Director). Learn More on Nevro's active insiders.

Kashif Rashid Insider Trading History at Nevro

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/9/2022	Buy	2,250	$44.50	$100,125.00	53,526
3/11/2022	Buy	1,500	$64.04	$96,060.00
11/11/2021	Buy	2,000	$101.05	$202,100.00

Kashif Rashid Buying and Selling Activity at Nevro

Nevro Company Overview

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Today's Range

Now: $4.52

$3.95

$4.57

50 Day Range

MA: $5.17

$4.07

$5.85

2 Week Range

Now: $4.52

$3.95

$22.64

Volume

1,398,600 shs

Average Volume

571,332 shs

Market Capitalization

$169.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93

Tech funds are hemorrhaging cash: Sell this stock now

From Chaikin Analytics | Ad